Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Liquid Biopsy for Biomarker Testing in Non-Small Cell Lung Cancer: A European Perspective
Umberto Malapelle, Marcello Tiseo, Ana Vivancos, et al.
Journal of Molecular Pathology (2021) Vol. 2, Iss. 3, pp. 255-273
Open Access | Times Cited: 29

Showing 1-25 of 29 citing articles:

Liquid Biopsies in Lung Cancer
Marcel Kemper, Carolin Krekeler, Kerstin Menck, et al.
Cancers (2023) Vol. 15, Iss. 5, pp. 1430-1430
Open Access | Times Cited: 26
Expert opinion on NSCLC small specimen biomarker testing — Part 2: Analysis, reporting, and quality assessment
Frédérique Penault‐Llorca, Keith M. Kerr, Pilar Garrido, et al.
Virchows Archiv (2022) Vol. 481, Iss. 3, pp. 351-366
Open Access | Times Cited: 34
Expert opinion on NSCLC small specimen biomarker testing — Part 1: Tissue collection and management
Frédérique Penault‐Llorca, Keith M. Kerr, Pilar Garrido, et al.
Virchows Archiv (2022) Vol. 481, Iss. 3, pp. 335-350
Open Access | Times Cited: 30
Tackling Non–Small Cell Lung Cancer in Young Adults: From Risk Factors and Genetic Susceptibility to Lung Cancer Profile and Outcomes
Juan Carlos Laguna, Marco Tagliamento, Matteo Lambertini, et al.
American Society of Clinical Oncology Educational Book (2024) Vol. 44, Iss. 3
Closed Access | Times Cited: 6
Circulating Tumour Cells: Detection and Application in Advanced Non-Small Cell Lung Cancer
Kalliopi Andrikou, Tania Rossi, Alberto Verlicchi, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 22, pp. 16085-16085
Open Access | Times Cited: 15
Pre-analytical conditions and implementation of quality control steps in liquid biopsy analysis
Aliki Ntzifa, Evi Lianidou
Critical Reviews in Clinical Laboratory Sciences (2023) Vol. 60, Iss. 8, pp. 573-594
Closed Access | Times Cited: 14
Accelerating the Development and Validation of Liquid Biopsy for Early Cancer Screening and Treatment Tailoring
Denis Horgan, Tanja Čufer, Francesco Gatto, et al.
Healthcare (2022) Vol. 10, Iss. 9, pp. 1714-1714
Open Access | Times Cited: 20
Liquid Biopsy in Solid Tumours: An Overview
Pasquale Pisapia, Antonino Iaccarino, Giancarlo Troncone, et al.
Cytopathology (2025)
Open Access
Incidental pathogenic germline alterations detected through liquid biopsy in patients with solid tumors: prevalence, clinical utility and implications
Juan Carlos Laguna, B. Pastor, I. Nalda, et al.
British Journal of Cancer (2024) Vol. 130, Iss. 9, pp. 1420-1431
Closed Access | Times Cited: 3
Liquid biopsy comprehensive genomic profiling of lung cancer in the Italian population: A real-world experience
Camilla Porta, Lorenzo Pradelli, Emilia Sicari, et al.
Lung Cancer (2023) Vol. 185, pp. 107359-107359
Closed Access | Times Cited: 8
Daily Practice Assessment of KRAS Status in NSCLC Patients: A New Challenge for the Thoracic Pathologist Is Right around the Corner
Christophe Bontoux, Véronique Hofman, Patrick Brest, et al.
Cancers (2022) Vol. 14, Iss. 7, pp. 1628-1628
Open Access | Times Cited: 12
Clinical utility of ctDNA by amplicon based next generation sequencing in first line non small cell lung cancer patients
Valerio Gristina, Tancredi Didier Bazan Russo, Nadia Barraco, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 2
Optimising tissue acquisition and the molecular testing pathway for patients with non-small cell lung cancer: A UK expert consensus statement
Neal Navani, Rachel Butler, Salma Ibrahimo, et al.
Lung Cancer (2022) Vol. 172, pp. 142-153
Open Access | Times Cited: 11
Association between Contrast-Enhanced Computed Tomography Radiomic Features, Genomic Alterations and Prognosis in Advanced Lung Adenocarcinoma Patients
Lisa Rinaldi, Elena Guerini‐Rocco, Gianluca Spitaleri, et al.
Cancers (2023) Vol. 15, Iss. 18, pp. 4553-4553
Open Access | Times Cited: 4
Liquid biopsy for the management of NSCLC patients under osimertinib treatment
Aliki Ntzifa, Theodoros Marras, Vassilis Georgoulias, et al.
Critical Reviews in Clinical Laboratory Sciences (2024) Vol. 61, Iss. 5, pp. 347-369
Closed Access | Times Cited: 1
Detection of genomic alterations in liquid biopsies from patients with non-small cell lung cancer using FoundationOne Liquid CDx: a cost-effectiveness analysis
Dolores Isla, Rosa Álvarez, María José Domper-Arnal, et al.
Journal of Medical Economics (2024) Vol. 27, Iss. 1, pp. 1379-1387
Open Access | Times Cited: 1
The Role of ctDNA in the Management of Non-Small-Cell Lung Cancer in the AI and NGS Era
José Luís Costa, Alexandro Membrino, Carol Zanchetta, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 24, pp. 13669-13669
Open Access | Times Cited: 1
Highly sensitive liquid biopsy Duplex sequencing complements tissue biopsy to enhance detection of clinically relevant genetic variants
Ariane Hallermayr, Teresa Neuhann, Verena Steinke‐Lange, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 5
Molecular Testing and Treatment Strategies in RET-Rearranged NSCLC Patients: Stay on Target to Look Forward
Maria Lucia Reale, Valentina Bertaglia, Angela Listì, et al.
Journal of Molecular Pathology (2022) Vol. 3, Iss. 1, pp. 24-37
Open Access | Times Cited: 4
Circulating Immune Proteins: Improving the Diagnosis and Clinical Outcome in Advanced Non-Small Cell Lung Cancer
Susana Torres, Sílvia Calabuig-Fariñas, Sandra Gallach, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 24, pp. 17587-17587
Open Access | Times Cited: 2
Impact of epidermal growth factor receptor T790M testing in relapsed non-small cell lung cancer
Kumar Prabhash, Ullas Batra
Cancer Research Statistics and Treatment (2021) Vol. 4, Iss. 4, pp. 692-701
Open Access | Times Cited: 5
Plasma-Based Genotyping in Advanced Solid Tumors: A Comprehensive Review
Maisam Makarem, Miguel García-Pardo, Natasha B. Leighl
Cancers (2021) Vol. 13, Iss. 21, pp. 5299-5299
Open Access | Times Cited: 4
The liquid biopsy series: A cytopathological perspective
Pasquale Pisapia, Umberto Malapelle, Philippe Vielh, et al.
Cytopathology (2023) Vol. 34, Iss. 6, pp. 517-518
Closed Access | Times Cited: 1
The Role of Liquid Biopsy for Detecting Epidermal Growth Factor Receptor (EGFR) Mutations in Patients with Advanced Non-Small Cell Lung Cancer (NSCLC) – A Preliminary Study in Indonesian Population
Agus Kosasih, Arif Riswahyudi Hanafi, Ninik Sukartini, et al.
Indonesian Journal of Cancer (2023) Vol. 17, Iss. 3, pp. 203-203
Open Access | Times Cited: 1
Global Landscape of Liquid Biopsy Research: Regional Contributions and Disparities
Siddig Ibrahim Abdelwahab, Abdullah Farasani, Hassan Ahmad Alfaifi, et al.
The Journal of Liquid Biopsy (2024) Vol. 6, pp. 100165-100165
Open Access
Page 1 - Next Page

Scroll to top